Strides Pharma Science Limited (STAR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Strides Pharma Science Limited (STAR) has a cash flow conversion efficiency ratio of 0.140x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.91 Billion ≈ $42.34 Million USD) by net assets (Rs28.03 Billion ≈ $303.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Strides Pharma Science Limited balance sheet independence to measure how much of total assets are equity-financed.
Strides Pharma Science Limited - Cash Flow Conversion Efficiency Trend (2005–2026)
This chart illustrates how Strides Pharma Science Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Strides Pharma Science Limited (STAR) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Strides Pharma Science Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Strides Pharma Science Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lihuayi Weiyuan Chemical Co Ltd
SHG:600955
|
0.006x |
|
Cyient Limited
NSE:CYIENT
|
0.071x |
|
Metals X Ltd
AU:MLX
|
0.134x |
|
Shanghai Industrial Development Co Ltd
SHG:600748
|
0.132x |
|
Shandong Laiwu Jinlei Wind Power Technology Co Ltd
SHE:300443
|
0.014x |
|
Xian Xice Testing Technology Co. Ltd. A
SHE:301306
|
N/A |
|
Simply Good Foods Co
NASDAQ:SMPL
|
0.005x |
|
Supalai Public Company Limited
BK:SPALI-R
|
0.012x |
Annual Cash Flow Conversion Efficiency for Strides Pharma Science Limited (2005–2026)
The table below shows the annual cash flow conversion efficiency of Strides Pharma Science Limited from 2005 to 2026. For the full company profile with market capitalisation and key ratios, see Strides Pharma Science Limited (STAR) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs31.49 Billion ≈ $340.59 Million |
Rs5.39 Billion ≈ $58.31 Million |
0.171x | -35.30% |
| 2025-03-31 | Rs25.86 Billion ≈ $279.72 Million |
Rs6.84 Billion ≈ $74.01 Million |
0.265x | -21.81% |
| 2024-03-31 | Rs20.72 Billion ≈ $224.05 Million |
Rs7.01 Billion ≈ $75.82 Million |
0.338x | +1555.68% |
| 2023-03-31 | Rs21.73 Billion ≈ $234.99 Million |
Rs444.11 Million ≈ $4.80 Million |
0.020x | +118.89% |
| 2022-03-31 | Rs23.83 Billion ≈ $257.75 Million |
Rs-2.58 Billion ≈ $-27.88 Million |
-0.108x | -163.23% |
| 2021-03-31 | Rs28.14 Billion ≈ $304.32 Million |
Rs4.81 Billion ≈ $52.07 Million |
0.171x | +116.77% |
| 2020-03-31 | Rs25.95 Billion ≈ $280.60 Million |
Rs2.05 Billion ≈ $22.15 Million |
0.079x | +268.20% |
| 2019-03-31 | Rs28.02 Billion ≈ $302.99 Million |
Rs600.55 Million ≈ $6.49 Million |
0.021x | -70.10% |
| 2018-03-31 | Rs26.09 Billion ≈ $282.18 Million |
Rs1.87 Billion ≈ $20.23 Million |
0.072x | -28.48% |
| 2017-03-31 | Rs28.74 Billion ≈ $310.86 Million |
Rs2.88 Billion ≈ $31.16 Million |
0.100x | +306.53% |
| 2016-03-31 | Rs29.06 Billion ≈ $314.27 Million |
Rs716.57 Million ≈ $7.75 Million |
0.025x | -65.60% |
| 2015-03-31 | Rs11.64 Billion ≈ $125.84 Million |
Rs834.00 Million ≈ $9.02 Million |
0.072x | +135.70% |
| 2014-03-31 | Rs10.82 Billion ≈ $117.07 Million |
Rs-2.17 Billion ≈ $-23.51 Million |
-0.201x | -413.53% |
| 2013-03-31 | Rs20.98 Billion ≈ $226.90 Million |
Rs1.34 Billion ≈ $14.53 Million |
0.064x | -80.13% |
| 2012-03-31 | Rs14.18 Billion ≈ $153.34 Million |
Rs4.57 Billion ≈ $49.43 Million |
0.322x | +54.77% |
| 2011-03-31 | Rs15.55 Billion ≈ $168.20 Million |
Rs3.24 Billion ≈ $35.03 Million |
0.208x | +255.34% |
| 2010-03-31 | Rs10.90 Billion ≈ $117.83 Million |
Rs638.65 Million ≈ $6.91 Million |
0.059x | -70.36% |
| 2009-03-31 | Rs5.96 Billion ≈ $64.42 Million |
Rs1.18 Billion ≈ $12.74 Million |
0.198x | -41.18% |
| 2008-03-31 | Rs2.94 Billion ≈ $31.74 Million |
Rs987.01 Million ≈ $10.67 Million |
0.336x | +34.31% |
| 2007-03-31 | Rs4.31 Billion ≈ $46.59 Million |
Rs1.08 Billion ≈ $11.66 Million |
0.250x | +9.80% |
| 2006-03-31 | Rs3.47 Billion ≈ $37.48 Million |
Rs790.26 Million ≈ $8.55 Million |
0.228x | -33.74% |
| 2005-03-31 | Rs2.18 Billion ≈ $23.54 Million |
Rs749.22 Million ≈ $8.10 Million |
0.344x | -- |
About Strides Pharma Science Limited
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products f… Read more